Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Biomed Res Int. 2020 Aug 4;2020:3682086. doi: 10.1155/2020/3682086. eCollection 2020.
The mechanisms that link obesity and cancer development are not well-defined. Investigation of leptin and leptin receptor expressions may help define some of the mechanisms. These proteins are known for associating with the immune response, angiogenesis and, signalling pathways such as JAK2/STAT3, PI3K, and AKT pathways. Tissue proteins can be easily detected with immunohistochemistry (IHC), a technique widely used both in diagnostic and research laboratories. The identification of altered levels of leptin and leptin receptor proteins in tumour tissues may lead to targeted treatment for cancer.
The objective of this study was to use IHC to compare leptin and leptin receptor expressions in clear cell renal cell carcinomas (ccRCC) in non-obese and obese patients to determine the association between these proteins with the clinicopathological features and prognosis of ccRCC. . The study involved 60 patients who underwent nephrectomy of which 34 were obese, as assessed using body mass index (BMI). Nephrectomy samples provided tissues of ccRCC and adjacent non-cancerous kidney. The intensity and localization of leptin and leptin receptor protein expressions were evaluated using IHC and correlated with clinicopathological features and clinical outcomes. Aperio ImageScope morphometry and digital pathology were applied to assess the IHC results. The chi-square test was used to determine if there was any significant association between the proteins and the clinicopathological features. The Kaplan-Meier test was used to determine the overall survival, disease-free survival, and recurrence-free survival. A value of < 0.05 was considered significant.
There was neither significant difference in the overall cellular and nuclear expressions of leptin and leptin receptor between non-cancerous kidney and ccRCC tissues nor in non-obese and obese individuals with ccRCC.
In this present study, it was revealed that leptin and leptin receptor were not associated with tumour characteristics and progression of ccRCC patients. Interestingly, nuclear expression of leptin was significantly associated with overall survival. However, the significance of these proteins as biomarkers in other RCC histotypes is still unclear.
肥胖与癌症发展之间的关联机制尚不清楚。对瘦素和瘦素受体表达的研究可能有助于确定部分机制。这些蛋白与免疫反应、血管生成以及 JAK2/STAT3、PI3K 和 AKT 等信号通路有关。免疫组织化学(IHC)是一种广泛应用于诊断和研究实验室的技术,可轻松检测组织蛋白。肿瘤组织中瘦素和瘦素受体蛋白水平的改变可能会导致针对癌症的靶向治疗。
本研究旨在通过 IHC 比较非肥胖和肥胖患者的透明细胞肾细胞癌(ccRCC)中瘦素和瘦素受体的表达,以确定这些蛋白与 ccRCC 的临床病理特征和预后之间的关联。研究共纳入 60 例接受肾切除术的患者,其中 34 例为肥胖患者,根据体重指数(BMI)进行评估。肾切除术样本提供了 ccRCC 及相邻非癌性肾脏组织。采用 IHC 评估瘦素和瘦素受体蛋白表达的强度和定位,并将其与临床病理特征和临床结果相关联。应用 Aperio ImageScope 形态计量学和数字病理学来评估 IHC 结果。卡方检验用于确定蛋白与临床病理特征之间是否存在显著关联。Kaplan-Meier 检验用于确定总生存率、无病生存率和无复发生存率。<0.05 被认为具有统计学意义。
非癌性肾脏和 ccRCC 组织中,以及非肥胖和肥胖的 ccRCC 患者中,瘦素和瘦素受体的整体细胞和核表达均无显著差异。
在本研究中,揭示了瘦素和瘦素受体与 ccRCC 患者的肿瘤特征和进展无关。有趣的是,瘦素的核表达与总生存率显著相关。然而,这些蛋白作为其他 RCC 组织类型的生物标志物的意义仍不清楚。